'We could have done without this': Romain Bardet on how Chris Froome case has damaged cycling
Ag2r La Mondiale leader hopes for quick resolution to case
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Sign up to our newsletter Newsletter

Romain Bardet has said that Chris Froome's adverse analytical finding (AAF) for high levels of salbutamol has damaged the credibility of cycling, and that he hopes for a quick resolution to the case.
Bardet, who finished third behind Froome at the Tour de France in July, said that the news that the Team Sky rider had twice the permitted level of asthma drug salbutamol in his urine after stage 18 of the Vuelta a España had an impact on everyone in the sport.
"This is not good news for cycling. Pretty much everyone gets hit by something like this, cycling's credibility first and foremost," Bardet told AFP (opens in new tab).
"We really could have done without it. It's not something anyone can rejoice about. Let's hope that a swift and objective probe can clarify the facts and leave no doubts about what happened."
>>> Everything you need to know about Chris Froome's salbutamol case
As the World Anti-Doping classifies salbutamol as a specified substance, Froome has not been given a provisional suspension. However in line with the UCI's anti-doping procedure, Froome's case will now be referred to the Legal Anti-Doping Services (LADS), with the rider and Team Sky being required to explain the elevated levels of salbutamol in Froome's system.
Riders have previously received sanctions for delivering high levels of salbutamol, with Diego Ulissi receiving a nine-month ban in 2014, and Alessandro Petacchi being banned for a year in 2007. However other riders have been cleared for medical reasons.
In a statement issued as news of Froome's AAF emerged on Wednesday, Team Sky said that it would be looking at a range of factors to explain the high levels of salbutamol in Froome's urine, with the aim of having its rider cleared through a pharmacokinetic study.
>>> Former UCI president Pat McQuaid: 'Hard to see how Sky can come of this with any credibility'
"There is considerable evidence to show that there are significant and unpredictable variations in the way salbutamol is metabolised and excreted.
"As a result, the use of permissible dosages of salbutamol can sometimes result in elevated urinary concentrations, which require explanation. A wide range of factors can affect the concentrations, including the interaction of salbutamol with food or other medications, dehydration and the timing of salbutamol usage before the test."
Froome himself has also denied any wrongdoing, saying that he will comply fully with the UCI's investigation.
>>> Chris Froome misses out on BBC Sports Personality of the Year award as Mo Farah wins
"It is well known that I have asthma and I know exactly what the rules are. I use an inhaler to manage my symptoms (always within the permissible limits) and I know for sure that I will be tested every day I wear the race leader’s jersey," the 32-year-old said.
"My asthma got worse at the Vuelta so I followed the team doctor’s advice to increase my salbutamol dosage. As always, I took the greatest care to ensure that I did not use more than the permissible dose.
"I take my leadership position in my sport very seriously. The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires."
Thank you for reading 10 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Henry Robertshaw began his time at Cycling Weekly working with the tech team, writing reviews, buying guides and appearing in videos advising on how to dress for the seasons. He later moved over to the news team, where his work focused on the professional peloton as well as legislation and provision for cycling. He's since moved his career in a new direction, with a role at the Department for Environment, Food and Rural Affairs.
-
-
Inspired by bikepacking events overseas, Rapha introduces the Rapha Yomp Rally
Rapha today announced the launch of the inaugural Rapha Yomp Rally, a five-day 375-mile adventure across some of the most stunning mixed-terrain roads California has to offer.
By Anne-Marije Rook • Published
-
From false promises and heartbreak to hope - How Heidi Franz is bouncing back from the last-minute collapse of B&B Hotels
Mind games, false promises and a life left in limbo. How American Heidi Franz navigated the B&B Hotels demise and found a kickstart to her new European life
By Anne-Marije Rook • Published
-
‘You never know in the Tour’ - Romain Bardet fearless as he lines up Tour de France GC bid
The 32-year-old is ready to play the tactical game this July
By Tom Davidson • Published
-
Chris Froome highlights dangers of long Covid after battle with virus
Four-time Tour de France champion warns of cardiovascular impact and says his VO2 max took a hit after illness
By Tom Thewlis • Published
-
Chris Froome labels WorldTour relegation a ‘death sentence for many teams’
Four-time Tour de France winner says UCI points system needs overhaul as Israel-PremierTech face relegation from the WorldTour
By Tom Thewlis • Last updated
-
Chris Froome still holds out hope for fifth Tour de France win
Israel-Premier Tech rider says the dream is "always there"
By Tom Davidson • Published
-
Chris Froome out of Tour de France after positive Covid-19 test result
Four-time winner and third on Alpe d’Huez stage forced to abandon on stage 18
By Tom Thewlis • Published
-
'I’m going to keep pushing. I don’t know what my limits are': Chris Froome climbs to best result since 2018
Israel-Premier Tech rider finished third on stage 12 of the Tour de France to Alpe d'Huez
By Adam Becket • Published
-
La Planche des Belles Filles: will today's Tour de France climb be make or break?
Primož Roglič may be looking to salvage his Tour de France by exorcising his 2020 demons on the brutal climb
By Tom Thewlis • Last updated
-
'GC is not the goal' — Romain Bardet and DSM will hunt stage wins at the Tour de France
Frenchman returns to home Grand Tour for the first time since 2020 next month
By Adam Becket • Published